NCT06925958View on ClinicalTrials.gov

A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma

NANot yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Multiple Myeloma (MM)
Interventions
DIAGNOSTIC_TEST

Flow cytometry

CD38 Flow cytometry testing

All Listed Sponsors
lead

The First Affiliated Hospital of Soochow University

OTHER

NCT06925958 - A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter